CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 
 
 
Biogen Inc.  (BIIB)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 
   Industry Biotechnology & Drugs
   Sector  Healthcare
 
Price: $330.9400 $3.67 1.121%
Day's High: $ 333.3 Week Perf: -3.52 %
Day's Low: $ 326.14 30 Day Perf: -2.83 %
Volume (M): 1,265 52 Wk High: $ 388.67
Volume (M$): $ 418,573 52 Wk Avg: $ 314.66
Open: 331.62 52 Wk Low: 249.17
You need to upgrade your Flash Player


 Market Capitalization (Millions $) 68,604
 Shares Outstanding (Millions) 207
 Employees 7,550
 Revenues (TTM) (Millions $) 12,872
 Net Income (TTM) (Millions $) 3,146
 Cash Flow (TTM) (Millions $) 97
 Capital Exp. (TTM) (Millions $) 1,862
Biogen Inc.
Biogen Idec creates new standards of care in oncology and immunology. As a global leader in the development, manufacturing, and commercialization of novel therapies, we transform scientific discoveries into advances in human healthcare. We currently have four commercial products: AVONEX® (Interferon beta-1a) for the treatment of relapsing multiple sclerosis, also known as MS, RITUXAN® (rituximab) and ZEVALIN® (ibritumomab tiuxetan), both of which treat certain B-cell non-Hodgkin’s lymphomas, also referred to as B-cell NHLs, and AMEVIVE® (alefacept) for the treatment of adult patients with moderate-to-severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy.


BIIB is expected to report next financial results on October 22, 2018.
 

Biogen's Segments
 
AVONEX
 Segment    29.25 % of total Revenue
TYSABRI
 Segment    22.02 % of total Revenue
PLEGRIDY
 Segment    3.54 % of total Revenue
Other
 Segment    -3.94 % of total Revenue
FAMPYRA
 Segment    1 % of total Revenue
TECFIDERA
 Segment    42 % of total Revenue
ALPROLIX
 Segment    2.59 % of total Revenue
ELOCTATE
 Segment    3.53 % of total Revenue
 
  Company Estimates  
  Revenue Outlook
Biogen announced annual revenue outlook on Jul. 24, 2015

Earnings Outlook
Biogen Inc. issued annual earnings guidance on Jul. 24, 2015

 
Geographic Revenue Dispersion
United States 74.12 %
Europe 15.3 %
Asia 8.74 %
Other 1.84 %

J C Penney Co Inc

J C Penney Co Inc announced second quarter operating deficit of $-36 millions

In the second quarter J C Penney Co Inc increased losses of $-0.32 per share compare to $-0.20 a year ago and increased losses from $-0.25 per share from the previous quarter.

Sales declined by -6.75 % to $2.76 billions from $2.96 billions in the same quarter a year ago and sequentially Sales increased by 6.89 % from $2.58 billions.

Verint Systems Inc

Turn into Profitability, Revenue up in Double Digits

Verint Systems Inc announced earnings per share of $0.33 and Sales of $289.21 millions in the second quarter, Company's turn a round per share, versus $-0.10 eps, earned in the same quarter a year ago, although Verint Systems Inc saw it's Sales rise by 11.48 % in the same period.

Wpp Plc

Break-even, Sales more than Double

In the forth quarter Wpp Plc reached break-even of $0.00 per share compare to $0.03 a year ago and from $0.00 per share from the previous quarter.

Sales increased sharply by 3226.7 % to $3.18 billions from $95.45 millions in the same quarter a year ago and sequentially from $0.00 millions.

Astronova, Inc.

Growth, Growth, Growth

Astronova, Inc showed respectable growth in the second quarter, where earnings jumped by 54.55 % year on year to $0.17 per share and Sales increased by 23.01 % to $33.81 millions.

Workday, Inc.

Despite Surge in Sales Profitability not Reached

Workday, Inc announced in the second quarter surge in Sales by 27.87 % to $671.72 millions from the same quarter a year ago, but it has lost money at $-0.40 per share.




BIIB's Valuation Current
Price to Earnings PE Ratio (TTM) 23.46
Price to Earnings PE Ratio (Expected) 22.86
Price to Sales (TTM) 5.33
Price to Sales (Expected) 6.15
Price to Book 5.6
PEG (TTM) -
BIIB's Financial Strength Current
Quick Ratio 1.02
Working Capital Ratio 2.36
Leverage Ratio (MRQ) 0.95
Total Debt to Equity 0.48
Interest Coverage (TTM) -
Debt Coverage (TTM) 1.03
Per Share Current
Earnings (TTM) 14.11 $
Revenues (TTM) 62.1 $
Cash Flow (TTM) 0.47 $
Cash 15.55 $
Book Value 59.11 $
Dividend (TTM) 2.85 $

• View Valuation Comparisons • View Growth Rates Comparisons

You need to upgrade your Flash Player
BIIB's Efficiency Current
Revenue per Employee (TTM) 1,704,954
Net Income per Employee (TTM) 416,689
Receivable Turnover Ratio (TTM) 7.11
Inventory Turnover Ratio (TTM) 1.87
Asset Turnover Ratio (TTM) 0.53
BIIB's Profitability Ratio Current
Gross Margin 87.46 %
Operating Margin 36.14 %
Net Margin 27.26 %
Net Cash Flow Margin -
Effective Tax Rate (TTM) 44.63 %
Management Effectiveness Current
Return On Assets (TTM) 13 %
Return On Investment (TTM) 15.05 %
Return On Equity (TTM) 24.32 %
Dividend Yield 0.86 %
Payout Ratio (TTM) 20.2 %
• View Efficiency Comparisons • View Profitability Comparisons • View Management Effectiveness


Customers Net Income fell by BIIB's customers Net margin fell to %
-5.3 % 3.38 %
• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers
You need to upgrade your Flash Player


You need to upgrade your Flash Player

   
You need to upgrade your Flash Player
Major Competitors Stock performance

5 Days Decrease / Increase
     
ABBV   -3.91%    
AMGN   -3.25%    
AGN   -3.62%    
JNJ   -3.76%    
BMY   -7.85%    
MRK   -1.72%    
• View Complete Report
   


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

UMED's Profile

Stock Price

UMED's Financials

Business Description

Fundamentals

Charts & Quotes

UMED's News

Suppliers

UMED's Competitors

Customers & Markets

Economic Indicators

UMED's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071